(Q44200353)

30 November 2017

title

Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model (English)

1 reference

30 November 2017

main subject

osteogenesis imperfecta

0 references

6

Adele L Boskey

1 reference

30 November 2017

Edith A McCarthy

1

1 reference

30 November 2017

Cathleen L Raggio

2

1 reference

30 November 2017

Michael D Hossack

3

1 reference

30 November 2017

Elizabeth A Miller

4

1 reference

30 November 2017

Sargam Jain

5

1 reference

30 November 2017

Nancy P Camacho

7

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

52

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

660-670

1 reference

https://scigraph.springernature.com/pub.10.1203/00006450-200211000-00010

30 November 2017

exact match

0 references

cites work

Osteogenesis imperfecta in childhood: treatment strategies.

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Genetic heterogeneity in osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Type V osteogenesis imperfecta: a new form of brittle bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Life expectancy in osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Osteogenesis imperfecta: practical treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Molecular mechanisms of action of bisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Basic biomechanical measurements of bone: a tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Method of histomorphometric assessment of glycosaminoglycans in articular cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Changes in cross-sectional geometry of the distal femoral metaphysis associated with inflammatory arthritis are reduced by a bisphosphonate (zoledronate).

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Bisphosphonates in bone diseases other than osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200211000-00010

10.1203/00006450-200211000-00010

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

30 November 2017

1027734305

0 references

1 reference